Literature DB >> 8925090

Liberation and analysis of protein-bound arsenicals.

M Styblo1, M F Hughes, D J Thomas.   

Abstract

Protein-bound arsenicals were liberated from binding sites on liver cytosolic proteins by exposure to 0.1 M CuCl at pH 1. This method released greater than 90% of the arsenicals associated with biological matrices. Ultrafiltrates of CuCl-treated cytosols were subjected to thin-layer chromatography to speciate and quantify inorganic and methylated arsenicals. For rat liver cytosol in an in vitro methylation assay and for liver and kidney cytosols from arsenite-treated mice, most inorganic arsenic was protein bound. Appreciable fractions of the organoarsenical metabolites present in these cytosols were also protein bound. Therefore, CuCl treatment of cytosols releases protein-bound arsenicals, permitting more accurate estimates of the pattern and extent of arsenic methylation in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8925090     DOI: 10.1016/0378-4347(95)00490-4

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  6 in total

1.  Analysis of arsenical metabolites in biological samples.

Authors:  Araceli Hernandez-Zavala; Zuzana Drobna; Miroslav Styblo; David J Thomas
Journal:  Curr Protoc Toxicol       Date:  2009-11

2.  Interspecies differences in metabolism of arsenic by cultured primary hepatocytes.

Authors:  Zuzana Drobná; Felecia S Walton; Anne W Harmon; David J Thomas; Miroslav Stýblo
Journal:  Toxicol Appl Pharmacol       Date:  2010-02-04       Impact factor: 4.219

3.  Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase.

Authors:  Zuzana Drobná; Stephen B Waters; Vicenta Devesa; Anne W Harmon; David J Thomas; Miroslav Stýblo
Journal:  Toxicol Appl Pharmacol       Date:  2005-09-01       Impact factor: 4.219

Review 4.  Arsenic binding to proteins.

Authors:  Shengwen Shen; Xing-Fang Li; William R Cullen; Michael Weinfeld; X Chris Le
Journal:  Chem Rev       Date:  2013-06-28       Impact factor: 60.622

5.  Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine.

Authors:  X C Le; M Ma; W R Cullen; H V Aposhian; X Lu; B Zheng
Journal:  Environ Health Perspect       Date:  2000-11       Impact factor: 9.031

6.  Arsenic exposure through drinking water increases the risk of liver and cardiovascular diseases in the population of West Bengal, India.

Authors:  Nandana Das; Somnath Paul; Debmita Chatterjee; Nilanjana Banerjee; Niladri S Majumder; Nilendu Sarma; Tanmoy J Sau; Santanu Basu; Saptarshi Banerjee; Papiya Majumder; Apurba K Bandyopadhyay; J Christopher States; Ashok K Giri
Journal:  BMC Public Health       Date:  2012-08-10       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.